117 related articles for article (PubMed ID: 11937343)
21. Correlation between reduction potentials and inhibitory effects on Epstein-Barr virus activation by emodin derivatives.
Koyama J; Inoue M; Morita I; Kobayashi N; Osakai T; Nishino H; Tokuda H
Cancer Lett; 2006 Sep; 241(2):263-7. PubMed ID: 16338070
[TBL] [Abstract][Full Text] [Related]
22. Abietane diterpenoids from the cones of Larix kaempferi and their inhibitory effects on Epstein-Barr virus activation.
Ohtsu H; Tanak R; In Y; Matsunaga S; Tokuda H; Nishino H
Planta Med; 2001 Feb; 67(1):55-60. PubMed ID: 11270723
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus activation by tung oil, extracts of Aleurites fordii and its diterpene ester 12-O-hexadecanoyl-16-hydroxyphorbol-13-acetate.
Ito Y; Yanase S; Tokuda H; Kishishita M; Ohigashi H; Hirota M; Koshimizu K
Cancer Lett; 1983 Feb; 18(1):87-95. PubMed ID: 6297709
[TBL] [Abstract][Full Text] [Related]
24. Search for possible antitumor promoters by inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation; ursolic acid and oleanolic acid from an anti-inflammatory Chinese medicinal plant, Glechoma hederaceae L.
Ohigashi H; Takamura H; Koshimizu K; Tokuda H; Ito Y
Cancer Lett; 1986 Feb; 30(2):143-51. PubMed ID: 3006912
[TBL] [Abstract][Full Text] [Related]
25. Identification of coumarins from lemon fruit (Citrus limon) as inhibitors of in vitro tumor promotion and superoxide and nitric oxide generation.
Miyake Y; Murakami A; Sugiyama Y; Isobe M; Koshimizu K; Ohigashi H
J Agric Food Chem; 1999 Aug; 47(8):3151-7. PubMed ID: 10552623
[TBL] [Abstract][Full Text] [Related]
26. Regioselective opening of myo-inositol orthoesters: mechanism and synthetic utility.
Godage HY; Riley AM; Woodman TJ; Thomas MP; Mahon MF; Potter BV
J Org Chem; 2013 Mar; 78(6):2275-88. PubMed ID: 23438216
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of stabilized analogues of glycoglycerolipids on Epstein-Barr virus activation and mouse skin tumor promotion.
Colombo D; Compostella F; Ronchetti F; Reza-Elahi S; Scala A; Toma L; Aoi W; Kuchide M; Takayasu J; Tokuda H; Nishino H
Cancer Lett; 2002 Dec; 186(1):37-41. PubMed ID: 12183073
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effects of lapachol derivatives on epstein-barr virus activation.
Sacau EP; Estévez-Braun A; Ravelo AG; Ferro EA; Tokuda H; Mukainaka T; Nishino H
Bioorg Med Chem; 2003 Feb; 11(4):483-8. PubMed ID: 12538012
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of herbal remedies on 12-O-tetradecanoylphorbol-13-acetate-promoted Epstein-Barr virus early antigen activation.
Kapadia GJ; Azuine MA; Tokuda H; Hang E; Mukainaka T; Nishino H; Sridhar R
Pharmacol Res; 2002 Mar; 45(3):213-20. PubMed ID: 11884218
[TBL] [Abstract][Full Text] [Related]
30. Sulfonate protecting groups. Improved synthesis of scyllo-inositol and its orthoformate from myo-inositol.
Sarmah MP; Shashidhar MS
Carbohydr Res; 2003 Apr; 338(9):999-1001. PubMed ID: 12681925
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus and tumor promoters.
Eliasson L; Nilsson MT; Kallin B; Klein G
Princess Takamatsu Symp; 1983; 14():139-45. PubMed ID: 6097578
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of 3-O-acyl-(+)-catechins on Epstein-Barr virus activation.
Uesato S; Taniuchi K; Kumagai A; Nagaoka Y; Seto R; Hara Y; Tokuda H; Nishino H
Chem Pharm Bull (Tokyo); 2003 Dec; 51(12):1448-50. PubMed ID: 14646330
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of some carbamates of myo-inositol.
Brufani M; Cesta MC; Donnarumma L; Filocamo L; Gostoli G; Lappa S; Ferrari E; Pagella PG
Carbohydr Res; 1992 Apr; 228(2):371-6. PubMed ID: 1525782
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and docking studies of novel antitumor benzimidazoles.
Omar MA; Shaker YM; Galal SA; Ali MM; Kerwin SM; Li J; Tokuda H; Ramadan RA; El Diwani HI
Bioorg Med Chem; 2012 Dec; 20(24):6989-7001. PubMed ID: 23123017
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of 3-modified 1D-myo-inositols as inhibitors and substrates of phosphatidylinositol synthase and inhibitors of myo-inositol uptake by cells.
Johnson SC; Dahl J; Shih TL; Schedler DJ; Anderson L; Benjamin TL; Baker DC
J Med Chem; 1993 Nov; 36(23):3628-35. PubMed ID: 8246231
[TBL] [Abstract][Full Text] [Related]
36. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J; Gradoville L; Daigle D; Miller G
J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
[TBL] [Abstract][Full Text] [Related]
37. myo-Inositol 1,3-acetals as early intermediates during the synthesis of cyclitol derivatives.
Gurale BP; Sardessai RS; Shashidhar MS
Carbohydr Res; 2014 Nov; 399():8-14. PubMed ID: 25216930
[TBL] [Abstract][Full Text] [Related]
38. Arachidonic acid cascade inhibitors modulate phorbol ester-induced oxidative stress in female ICR mouse skin: differential roles of 5-lipoxygenase and cyclooxygenase-2 in leukocyte infiltration and activation.
Nakamura Y; Kozuka M; Naniwa K; Takabayashi S; Torikai K; Hayashi R; Sato T; Ohigashi H; Osawa T
Free Radic Biol Med; 2003 Nov; 35(9):997-1007. PubMed ID: 14572603
[TBL] [Abstract][Full Text] [Related]
39. Stereoselective synthesis of bishomo-inositols as glycosidase inhibitors.
Baran A; Balci M
J Org Chem; 2009 Jan; 74(1):88-95. PubMed ID: 19113902
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of lantadenes and related triterpenoids on Epstein-Barr virus activation.
Inada A; Nakanishi T; Tokuda H; Nishino H; Iwashima A; Sharma OP
Planta Med; 1995 Dec; 61(6):558-9. PubMed ID: 8824951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
